Cargando…

BRCA2 Heterozygosity Delays Cytokinesis in Primary Human Fibroblasts

Background: Inherited mutations in the tumour suppressor gene BRCA2 greatly increase the risk of developing breast, ovarian and other types of cancers. So far, most studies have focused on the role of BRCA-pathways in the maintenance of genomic stability. In this study we investigated the potential...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jonsdottir, Asta Björk, Vreeswijk, Maaike P. G., Wolterbeek, Ron, Devilee, Peter, Tanke, Hans J., Eyfjörd, Jorunn E., Szuhai, Karoly
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2009
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618909/ https://www.ncbi.nlm.nih.gov/pubmed/19478387 http://dx.doi.org/10.3233/CLO-2009-0465

Ejemplares similares

Centriole movements in mammalian epithelial cells during cytokinesis
por: Jonsdottir, Asta Björk, et al.
Publicado: (2010)

The Carcinoma–Stromal Ratio of Colon Carcinoma Is an Independent Factor for Survival Compared to Lymph Node Status and Tumor Stage
por: Mesker, Wilma E., et al.
Publicado: (2007)

The Icelandic founder mutation BRCA2 999del5: analysis of expression
por: Mikaelsdottir, Evgenia K, et al.
Publicado: (2004)

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Maxwell, Kara N., et al.
Publicado: (2017)

Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13.
por: Cleton-Jansen, A. M., et al.
Publicado: (1995)

BRCA2 Haploinsufficiency in Telomere Maintenance
por: Gunnarsdottir, Soffía R., et al.
Publicado: (2021)

Presence of a High Amount of Stroma and Downregulation of SMAD4 Predict for Worse Survival for Stage I–II Colon Cancer Patients
por: Mesker, Wilma E., et al.
Publicado: (2009)

Value of the loss of heterozygosity to BRCA1 variant classification
por: Santana dos Santos, Elizabeth, et al.
Publicado: (2022)

Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer
por: Birgisdottir, Valgerdur, et al.
Publicado: (2006)

Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes
por: Stefansson, Olafur Andri, et al.
Publicado: (2009)

BRCA2 mutation carriers, reproductive factors and breast cancer risk
por: Tryggvadottir, Laufey, et al.
Publicado: (2003)

Correction: Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes
por: Stefansson, Olafur Andri, et al.
Publicado: (2009)

Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer.
por: Beckmann, M. W., et al.
Publicado: (1996)

Clinicopathological Characterization of Double Heterozygosity for BRCA1 and BRCA2 Variants in Korean Breast Cancer Patients
por: Bang, Yoon Ju, et al.
Publicado: (2022)

Prognostic value of loss of heterozygosity at BRCA2 in human breast carcinoma.
por: BiÃ¨che, I., et al.
Publicado: (1997)

Mechanisms of increased risk of tumorigenesis in Atm and Brca1 double heterozygosity
por: Wang, Jufang, et al.
Publicado: (2011)

The functional impact of variants of uncertain significance in BRCA2
por: Mesman, Romy L. S., et al.
Publicado: (2018)

Rapid detection of genomic imbalances using micro-arrays consisting of pooled BACs covering all human chromosome arms
por: Knijnenburg, Jeroen, et al.
Publicado: (2005)

Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer
por: Kloth, Judith N, et al.
Publicado: (2007)

Aurora A is a prognostic marker for breast cancer arising in BRCA2 mutation carriers
por: Aradottir, Margret, et al.
Publicado: (2014)

BRCA2 interacting proteins
por: Vidarsson, H, et al.
Publicado: (2000)

Double Heterozygosity for Rare Deleterious Variants in the BRCA1 and BRCA2 Genes in a Hungarian Patient with Breast Cancer
por: Madar, László, et al.
Publicado: (2023)

Estrogen receptor transcription and transactivation: Genetic modifiers of cancer risks conferred by BRCA1 and BRCA2
por: Devilee, P
Publicado: (2001)

BRCA1 and BRCA2 Germline Mutations Screening in Algerian Breast/Ovarian Cancer Families
por: Cherbal, Farid, et al.
Publicado: (2010)

BRCA1 and BRCA2 Unclassified Variants and Missense Polymorphisms in Algerian Breast/Ovarian Cancer Families
por: Cherbal, Farid, et al.
Publicado: (2012)

Mutation Analysis of the BRCA1 and BRCA2 Genes in the Belgian Patient Population and Identification of a Belgian Founder Mutation BRCA1 IVS5+3A>G
por: Claes, Kathleen, et al.
Publicado: (1999)

Alternative mRNA splicing can attenuate the pathogenicity of presumed loss-of-function variants in BRCA2
por: Mesman, Romy L. S., et al.
Publicado: (2020)

Genomic and phenotypic analysis of BRCA2 mutated breast cancers reveals co-occurring changes linked to progression
por: Stefansson, Olafur A, et al.
Publicado: (2011)

BRCA1 Promoter Methylation Status in 1031 Primary Breast Cancers Predicts Favorable Outcomes Following Chemotherapy
por: Stefansson, Olafur A, et al.
Publicado: (2019)

Hereditary Susceptibility to Breast Cancer: Significance of Age of Onset in Family History and Contribution of BRCA1 and BRCA2
por: Frank, Thomas S., et al.
Publicado: (1999)

Correction: Alternative mRNA splicing can attenuate the pathogenicity of presumed loss-of-function variants in BRCA2
por: Mesman, Romy L. S., et al.
Publicado: (2020)

CpG island hypermethylation of BRCA1 and loss of pRb as co-occurring events in basal/triple-negative breast cancer
por: Stefansson, Olafur Andri, et al.
Publicado: (2011)

Pan-Cancer Analysis of BRCA1 and BRCA2 Genomic Alterations and Their Association With Genomic Instability as Measured by Genome-Wide Loss of Heterozygosity
por: Sokol, Ethan S., et al.
Publicado: (2020)

Mapping loss of heterozygosity in normal human breast cells from BRCA1/2 carriers
por: Clarke, C L, et al.
Publicado: (2006)

Double Heterozygosity of BRCA2 and STK11 in Familial Breast Cancer Detected by Exome Sequencing
por: ATAEI-KACHOUEI, Mojgan, et al.
Publicado: (2015)

Clues to the Function of the Tumour Susceptibility Gene BRCA2
por: Gayther, Simon A., et al.
Publicado: (1998)

Forced expression of chimeric human fibroblast tropomyosin mutants affects cytokinesis
Publicado: (1995)

Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations
por: Gonzalez, R, et al.
Publicado: (1999)

PCR-based microsatellite polymorphisms in the detection of loss of heterozygosity in fresh and archival tumour tissue.
por: Gruis, N. A., et al.
Publicado: (1993)

Complete Mutation Screening and Haplotype Characterization of the BRCA1 Gene in 61 Familial Breast Cancer Patients from Norway
por: Frost, Petter, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_233l8js7gv6stvh5dv81gfnonc